Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > DYN Dyne Therapeutics > Detailed Quotes

DYN Dyne Therapeutics

12.720
+0.020+0.16%
Trading Session 10/03 14:41 ET
High
12.940
Open
12.700
Turnover
468.53K
Low
12.410
Pre Close
12.700
Volume
36.98K
Market Cap
658.46M
P/E(TTM)
Loss
52wk High
16.390
Shares
51.77M
P/E(Static)
Loss
52wk Low
4.300
Float Cap
204.91M
Bid/Ask %
0.00%
Historical High
36.570
Shs Float
16.11M
Volume Ratio
0.08
Historical Low
4.300
Dividend TTM
--
Div Yield TTM
--
P/B
2.29
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.23%
Amplitude
4.17%
Avg Price
12.670
Lot Size
1
Float Cap
204.91M
Bid/Ask %
0.00%
Historical High
36.570
Shs Float
16.11M
Volume Ratio
0.08
Historical Low
4.300
Dividend TTM
--
P/B
2.29
Dividend LFY
--
Turnover Ratio
0.23%
Amplitude
4.17%
Avg Price
12.670
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
CEO: Mr. Joshua T. Brumm
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...